Vaccination of boars with a GnRH vaccine (Improvac) eliminates boar taint and increases growth performance
- PMID: 11721830
- DOI: 10.2527/2001.79102524x
Vaccination of boars with a GnRH vaccine (Improvac) eliminates boar taint and increases growth performance
Abstract
Peri- and postpubertal boars accumulate substances (e.g., androstenone and skatole) in their fatty tissue that are responsible for boar taint in pork. The objective of this study was to assess the efficacy of a GnRH vaccine, Improvac, in eliminating boar taint. Three hundred male (200 intact boars, 100 barrows) crossbred (Large White x Landrace) pigs were used in a 2 x 3 factorially arranged experiment. The respective factors were sex group (barrows, boars treated with placebo, or boars treated with Improvac) and slaughter age (23 or 26 wk). Vaccines were administered 8 and 4 wk before slaughter. All Improvac-treated pigs exhibited anti-GnRH titers. Testes and bulbo-urethral gland weights in treated pigs were reduced by approximately 50% (P < 0.001) and serum testosterone levels were below 2 ng/mL in the majority of treated boars (94 and 92% across both age groups at 2 and 4 wk, respectively). Boar taint, as assessed by the concentration of androstenone and skatole in s.c. fat, was suppressed to low or undetectable levels in 100% of Improvac-treated boars. No Improvac-treated pigs had significant concentrations of either androstenone (> 1.0 microg/g) or skatole (> 0.20 microg/g). In contrast, 49.5% of placebo-treated controls had significant androstenone and 10.8% had significant skatole levels, resulting in 10% of the control boars with high concentrations of both compounds. The mean concentrations of taint compounds in the Improvac-treated pigs were not significantly different from those in barrows. Improvac-treated boars grew more rapidly (P = 0.051 and < 0.001 for pigs slaughtered at 23 and 26 wk of age, respectively) than control boars over the 4 wk after the secondary vaccination, possibly because of reduced sexual and aggressive activities. Compared with barrows, Improvac-treated boars were leaner and had superior feed conversion efficiency. The vaccine was well tolerated by the pigs, and no observable site reactions could be detected at the time of slaughter. Vaccination of boars with Improvac allows production of heavy boars with improved meat quality through prevention and control of boar taint.
Similar articles
-
Effect of a gonadotropin-releasing hormone vaccine (Improvac) on steroid hormones, boar taint compounds and performance in entire male pigs.Reprod Domest Anim. 2008 Jun;43(3):351-359. doi: 10.1111/j.1439-0531.2007.00914.x. Epub 2007 Dec 11. Reprod Domest Anim. 2008. PMID: 18086253
-
Strategic use of anti-GnRH vaccine allowing selection of breeding boars without adverse effects on reproductive or production performances.Theriogenology. 2016 Feb;85(3):476-82. doi: 10.1016/j.theriogenology.2015.09.027. Epub 2015 Sep 21. Theriogenology. 2016. PMID: 26474682
-
Reducing the length of time between slaughter and the secondary gonadotropin-releasing factor immunization improves growth performance and clears boar taint compounds in male finishing pigs.J Anim Sci. 2011 Sep;89(9):2782-92. doi: 10.2527/jas.2010-3267. Epub 2011 Apr 21. J Anim Sci. 2011. PMID: 21512121
-
Managing Boar Taint: Issues, Prevention Strategies, and Detection Methods.Anim Sci J. 2025 Jan-Dec;96(1):e70090. doi: 10.1111/asj.70090. Anim Sci J. 2025. PMID: 40804789 Review.
-
Recent genetic advances on boar taint reduction as an alternative to castration: a review.J Appl Genet. 2021 Feb;62(1):137-150. doi: 10.1007/s13353-020-00598-w. Epub 2021 Jan 6. J Appl Genet. 2021. PMID: 33405214 Free PMC article. Review.
Cited by
-
BOARD INVITED REVIEW: Immunocontraception as a possible tool to reduce feral pig populations: recent and future perspectives.J Anim Sci. 2019 May 30;97(6):2283-2290. doi: 10.1093/jas/skz066. J Anim Sci. 2019. PMID: 30753509 Free PMC article. Review.
-
Contraceptive effect of a gonadotropin-releasing hormone vaccine on a captive female African Lion (Panthera leo): a case study.J Vet Med Sci. 2021 Sep 15;83(9):1454-1458. doi: 10.1292/jvms.21-0032. Epub 2021 Jul 19. J Vet Med Sci. 2021. PMID: 34275960 Free PMC article.
-
Structure-guided design and evaluation of CRM197-scaffolded vaccine targeting GnRH for animal immunocastration.Appl Microbiol Biotechnol. 2024 Nov 9;108(1):507. doi: 10.1007/s00253-024-13348-3. Appl Microbiol Biotechnol. 2024. PMID: 39520573 Free PMC article.
-
Carcass cutting yields and meat quality of market gilts managed with immunological suppression of ovarian function and estrus.Transl Anim Sci. 2024 Oct 5;8:txae145. doi: 10.1093/tas/txae145. eCollection 2024. Transl Anim Sci. 2024. PMID: 39444713 Free PMC article.
-
Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses.Allergy. 2019 Mar;74(3):572-582. doi: 10.1111/all.13659. Epub 2018 Nov 25. Allergy. 2019. PMID: 30402930 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical